Local delivery of nitric oxide: Targeted delivery of therapeutics to bone and connective tissues

Advanced Drug Delivery Reviews

Volumn 64, Issue 12, 2012, Pages 1177-1188

  Nichols, Scott P ^a   Storm, Wesley L ^a   Koh, Ahyeon ^a   Schoenfisch, Mark H ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Collagen; Diabetes; N diazeniumdiolate; Organic nitrate; Osteoblast; Osteoclast; Osteoporosis; S nitrosothiol; Tendon repair; Wound healing

Indexed keywords

N-DIAZENIUMDIOLATE; ORGANIC NITRATES; OSTEOCLAST; OSTEOPOROSIS; S-NITROSOTHIOL; WOUND HEALING;

BIOACTIVITY; BONE; COLLAGEN; MEDICAL PROBLEMS; NITRIC OXIDE; NONINVASIVE MEDICAL PROCEDURES; OSTEOBLASTS;

TENDONS;

1 [N (AMINOETHYL) N (2 AMINOETHYL)AMINO]DIAZEN 1 IUM 1,2 DIOLATE; ARGININE; BISPHOSPHONIC ACID DERIVATIVE; BOVINE SERUM ALBUMIN; CHITOSAN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; FLURBIPROFEN 4 NITROXYBUTYL ESTER; GANTREZ COPOLYMER; GLYCERYL TRINITRATE; IBANDRONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; MOLSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NAPROXCINOD; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; NITROBISPHOSPHONATE DERIVATIVE; NITROBOVINE SERUM ALBUMIN; NITROPARACETAMOL; NITROPRUSSIDE SODIUM; OSTEOCLAST DIFFERENTIATION FACTOR; PARACETAMOL DERIVATIVE; POLYVINYL ALCOHOL; POTASSIUM NITROSYLPENTACHLORORUTHENATE; POVIDONE; S NITROSOGLUTATHIONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACHILLES TENDINITIS; BONE; BONE REMODELING; BURN; CLINICAL TRIAL (TOPIC); CONNECTIVE TISSUE; DIABETIC FOOT; DRUG DELIVERY SYSTEM; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; DRUG RELEASE; DRUG TARGETING; ENZYME ACTIVITY; FEMUR FRACTURE; FRACTURE HEALING; HUMAN; HYPERTENSION; IMPLANT; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; TENDON INJURY; WOUND HEALING;

ANIMALS; BONE AND BONES; CONNECTIVE TISSUE; DRUG DELIVERY SYSTEMS; HUMANS; NITRIC OXIDE; NITRIC OXIDE DONORS; SKIN; TENDONS; WOUND HEALING;

EID: 84865293013     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.03.002     Document Type: Review

References (171)

1. Hetrick E.M., Schoenfisch M.H. Reducing implant-related infections: active release strategies. Chem. Soc. Rev. 2006, 35:780-789.
2. Simchi A., Tamjid E., Pishbin F., Boccaccini A.R. Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomed. Nanotechnol. Biol. Med. 2011, 7:22-39.
3. Rodan G.A., Martin T.J. Therapeutic Approaches to Bone Diseases. Science 2000, 289:1508-1514.
4. Bilezikian J.P., Raisz L.G., Rodan G.A. Principles of bone biology 1996, Academic Press, San Diego.
5. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
6. Laurencin C.T., Ambrosio A.M.A., Borden M.D., Cooper J.A. Tissue engineering: orthopedic applications. Annu. Rev. Biomed. Eng. 1999, 1:19-46.
7. Ignarro L.J. Nitric oxide: biology and pathobiology 2000, Academic, San Diego, Calif.; London.
8. Williams D.L.H. A chemist's view of the nitric oxide story. Org. Biomol. Chem. 2003, 1:441-449.
9. Griffith O.W., Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 1995, 57:707-734.
10. Malinski T., Taha Z., Grunfeld S., Patton S., Kapturczak M., Tomboulian P. Diffusion of Nitric Oxide in the Aorta Wall Monitored in Situ by Porphyrinic Microsensors. Biochem. Biophys. Res. Commun. 1993, 193:1076-1082.
11. Nablo B.J., Prichard H.L., Butler R.D., Klitzman B., Schoenfisch M.H. Inhibition of implant-associated infections via nitric oxide release. Biomaterials 2005, 26:6984-6990.
12. Hrabie J.A., Keefer L.K. Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives. Chem. Rev. 2002, 102:1135-1154.
13. Davies K.M., Wink D.A., Saavedra J.E., Keefer L.K. Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. J. Am. Chem. Soc. 2001, 123:5473-5481.
14. Williams D.L.H. The chemistry of S-nitrosothiols. Acc. Chem. Res. 1999, 32:869-876.
15. Seabra A.B., Duran N. Nitric oxide-releasing vehicles for biomedical applications. J. Mater. Chem. 2010, 20:1624-1637.
16. Keefer L.K., Nims R.W., Davies K.M., Wink D.A. "'NONOates"' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 1996, 268:281-293.
17. Riccio D.A., Dobmeier K.P., Hetrick E.M., Privett B.J., Paul H.S., Schoenfisch M.H. Nitric oxide-releasing S-nitrosothiol-modified xerogels. Biomaterials 2009, 30:4494-4502.
18. Shin J.H., Metzger S.K., Schoenfisch M.H. Synthesis of nitric oxide-releasing silica nanoparticles. J. Am. Chem. Soc. 2007, 129:4612-4619.
19. Shin J.H., Schoenfisch M.H. Inorganic/Organic Hybrid Silica Nanoparticles as a Nitric Oxide Delivery Scaffold. Chem. Mater. 2008, 20:239-249.
20. Riccio D.A., Nugent J.L., Schoenfisch M.H. Stober Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles. Chem. Mater. 2011, 23:1727-1735.
21. Stasko N.A., Schoenfisch M.H. Dendrimers as a scaffold for nitric oxide release. J. Am. Chem. Soc. 2006, 128:8265-8271.
22. Stasko N.A., Fischer T.H., Schoenfisch M.H. S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. Biomacromolecules 2008, 9:834-841.
23. Mowery K.A., Schoenfisch M.H., Saavedra J.E., Keefer L.K., Meyerhoff M.E. Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials 2000, 21:9-21.
24. Parzuchowski P.G., Frost M.C., Meyerhoff M.E. Synthesis and Characterization of Polymethacrylate-Based Nitric Oxide Donors. J. Am. Chem. Soc. 2002, 124:12182-12191.
25. Coneski P.N., Rao K.S., Schoenfisch M.H. Degradable Nitric Oxide-Releasing Biomaterials via Post-Polymerization Functionalization of Cross-Linked Polyesters. Biomacromolecules 2010, 11:3208-3215.
26. Coneski P.N., Nash J.A., Schoenfisch M.H. Nitric Oxide-Releasing Electrospun Polymer Microfibers. ACS Appl. Mater. Interfaces 2011, 3:426-432.
27. Wang P.G., Xian M., Tang X., Wu X., Wen Z., Cai T., Janczuk A.J. Nitric oxide donors: chemical activities and biological applications. Chem. Rev. 2002, 102:1091-1134.
28. Murad F. The excitement and rewards of research with our discovery of some of the biological effects of nitric oxide. Circ. Res. 2003, 92:339-341.
29. Chen Z., Zhang J., Stamler J.S. Identification of the enzymatic mechanism of nitroglycerin bioactivation. PNAS 2002, 99:8306-8311.
30. Chen Z., Foster M.W., Zhang J., Mao L., Rockman H.A., Kawamoto T., Kitagawa K., Nakayama K.I., Hess D.T., Stamler J.S. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. PNAS 2005, 102:12159-12164.
31. Sydow K., Daiber A., Oelze M., Chen Z., August M., Wendt M., Ullrich V., Mülsch A., Schulz E., John J., Keaney F., Stamler J.S., Münzel T. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J. Clin. Invest. 2004, 113:482-489.
32. Daiber A., Oelze M., Coldewey M., Bachschmid M., Wenzel P., Sydow K., Wendt M., Kleschyov A.L., Stalleicken D., Ullrich V., M[U+CCB4]lsch A., M[U+CCB4]nzel T. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol. Pharmacol. 2004, 66:1372-1382.
33. McCleverty J.A. Chemistry of Nitric Oxide Relevant to Biology. Chem. Rev. 2004, 104:403-418.
34. Yip K.-P. Flash photolysis of caged nitric oxide inhibits proximal tubular fluid reabsorption in free-flow nephron. Am. J. Physiol. Regul. Integr. 2005, 289:R620-R626.
35. Bettache N., Carter T., Corrie J.E.T., Ogden D., Trentham D.R. Photolabile donors of nitric oxide: ruthenium nitrosyl chlorides as caged nitric oxide. Methods Enzymol. 1996, 268:266-281.
36. Teitelbaum S.L. Bone Resorption by Osteoclasts. Science 2000, 289:1504-1508.
37. Aguirre J., Buttery L., O'Shaughnessy M., Afzal F. I.g. Fernandez de Marticorena, M. Hukkanen, P. Huang, I. MacIntyre, J. Polak, Endothelial Nitric Oxide Synthase Gene-Deficient Mice Demonstrate Marked Retardation in Postnatal Bone Formation, Reduced Bone Volume, and Defects in Osteoblast Maturation and Activity. Am. J. Pathol. 2001, 158:247-257.
38. Afzal F., Polak J., Buttery L. Endothelial nitric oxide synthase in the control of osteoblastic mineralizing activity and bone integrity. J. Pathol. 2004, 202:503-510.
39. Collin-Osdoby P., Rothe L., Bekker S., Anderson F., Osdoby P. Decreased Nitric Oxide Levels Stimulate Osteoclastogenesis and Bone Resorption Both in Vitro and in Vivo on the Chick Chorioallantoic Membrane in Association with Neoangiogenesis. J. Bone Miner. Res. 2000, 15:474-488.
40. Ralston S.H., Ho L.-P., Helfrich M.H., Grabowski P.S., Johnston P.W., Benjamin N. Nitric oxide: a cytokine-induced regulator of bone resorption. J. Bone Miner. Res. 1995, 10:1040-1049.
41. Nilforoushan D., Gramoun A., Glogauer M., Manolson M.F. Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion. Nitric Oxide Biol. Chem. 2009, 21:27-36.
42. Hughes D.E., Dai A., Tiffee J.C., Li H.H., Mundy G.R., Boyce B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-[beta]. Nat. Med. 1996, 2:1132-1136.
43. Armour K.E., Ralston S.H. Estrogen Upregulates Endothelial Constitutive Nitric Oxide Synthase Expression in Human Osteoblast-Like Cells. Endocrinology 1998, 139:799-802.
44. O'Shaughnessy M.C., Polak J.M., Afzal F., Hukkanen M.V.J., Huang P., MacIntyre I., Buttery L.D.K. Nitric Oxide Mediates 17[beta]-Estradiol-Stimulated Human and Rodent Osteoblast Proliferation and Differentiation. Biochem. Biophys. Res. Commun. 2000, 277:604-610.
45. Armour K.E., Armour K.J., Gallagher M.E., Godecke A., Helfrich M.H., Reid D.M., Ralston S.H. Defective Bone Formation and Anabolic Response to Exogenous Estrogen in Mice with Targeted Disruption of Endothelial Nitric Oxide Synthase. J. Endocrinol. 2001, 142:760-766.
46. Wimalawansa S.J. Nitric oxide: novel therapy for osteoporosis. Expert Opin. Pharmacother. 2008, 9:3025-3044.
47. Diwan A.D., Wang M.X., Jang D., Zhu W., Murrell G.A.C. Nitric Oxide Modulates Fracture Healing. J. Bone Miner. Res. 2000, 15:342-351.
48. Baldik Y., Diwan A.D., Appleyard R.C., Ming Fang Z., Wang Y., Murrell G.A.C. Deletion of iNOS gene impairs mouse fracture healing. Bone 2005, 37:32-36.
49. Rubin J., Murphy T., Nanes M.S., Fan X. Mechanical strain inhibits expression of osteoclast differentiation factor by murine stromal cells. Am. J. Physiol. Cell Physiol. 2000, 278:C1126-C1132.
50. Rubin J., Fan X., Biskobing D.M., Taylor W.R., Rubin C.T. Osteoclastogenesis is repressed by mechanical strain in an in vitro model. J. Orthop. Res. 1999, 17:639-645.
51. Rangaswami H., Marathe N., Zhuang S., Chen Y., Yeh J.-C., Frangos J.A., Boss G.R., Pilz R.B. Type II cGMP-dependent Protein Kinase Mediates Osteoblast Mechanotransduction. J. Biol. Chem. 2009, 284:14796-14808.
52. Rubin J., Murphy T.C., Zhu L., Roy E., Nanes M.S., Fan X. Mechanical Strain Differentially Regulates Endothelial Nitric-oxide Synthase and Receptor Activator of Nuclear KB Ligand Expression via ERK1/2 MAPK. J. Biol. Chem. 2003, 278:34018-34025.
53. Rahnert J., Fan X., Case N., Murphy T.C., Grassi F., Sen B., Rubin J. The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells. Bone 2008, 43:48-54.
54. Otsuka E., Hirano K., Matsushita S., Inoue A., Shigehisa H., Yamaguchi A., Hagiwara H. Effects of nitric oxide from exogenous nitric oxide donors on osteoblastic metabolism. Eur. J. Pharmacol. 1998, 349:345-350.
55. Mancini L., Moradi-Bidhendi N., Becherini L., Martineti V., MacIntyre I. The Biphasic Effects of Nitric Oxide in Primary Rat Osteoblasts Are cGMP Dependent. Biochem. Biophys. Res. Commun. 2000, 274:477-481.
56. Radomski M.W., Palmer R.M.J., Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 1987, 148:1482-1489.
57. Ignarro L.J., Harbison R.G., Wood K.S., Kadowitz P.J. Activation of purified soluble guanylate-cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein-stimulation by acetylcholine, bradykinn and arachidonic-acid. J. Pharmacol. Exp. Ther. 1986, 237:893-900.
58. Hagiwara H., Inoue A., Yamaguchi A., Yokose S., Furuya M., Tanaka S., Hirose S. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am. J. Physiol. Cell Physiol. 1996, 270:C1311-C1318.
59. Otsuka E., Hirano K., Matsushita S., Inoue A., Hirose S., Yamaguchi A., Hagiwara H. Effects of nitric oxide from exogenous nitric oxide donors on osteoblastic metabolism. Eur. J. Pharmacol. 1998, 349:345-350.
60. Broderick K.E., Zhang T., Rangaswami H., Zeng Y., Zhao X., Boss G.R., Pilz R.B. Guanosine 3 ',5 '-cyclic monophosphate (cGMP)/cGMP-dependent protein kinase induce interleukin-6 transcription in osteoblasts. Mol. Endocrinol. 2007, 21:1148-1162.
61. Chen R.M., Chen T.L., Chiu W.T., Chang C.C. Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J. Orthop. Res. 2005, 23:462-468.
62. Van 't Hof R.J., Ralston S.H. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J. Bone Miner. Res. 1997, 12:1797-1804.
63. Lee S.K., Huang H., Lee S.W., Kim K.H., Kim K.K., Kim H.-M., Lee Z.H., Kim H.-H. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-[alpha]. Exp. Cell Res. 2004, 298:359-368.
64. Kanaoka K., Kobayashi Y., Hashimoto F., Nakashima T., Shibata M., Kobayashi K., Kato Y., Sakai H. A Common Downstream Signaling Activity of Osteoclast Survival Factors That Prevent Nitric Oxide-Promoted Osteoclast Apoptosis. J. Endocrinol. 2000, 141:2995-3005.
65. Zheng H., Yu X., Collin-Osdoby P., Osdoby P. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts-an autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappa B that restrains osteoclastogenesis and bone resorption. J. Biol. Chem. 2006, 281:15809-15820.
66. Hetrick E.M., Schoenfisch M.H. Antibacterial nitric oxide-releasing xerogels: cell viability and parallel plate flow cell adhesion studies. Biomaterials 2007, 28:1948-1956.
67. Holliday L.S., Dean A.D., Lin R.H., Greenwald J.E., Gluck S.L. Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am. J. Physiol. Ren. 1997, 272:F283-F291.
68. Holliday L.S., Dean A.D., Lin R.H., Greenwald J.E., Gluck S.L. Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am. J. Physiol. Renal Physiol. 1997, 272:F283-F291.
69. MacIntyre I., Zaidi M., Alam A.S., Datta H.K., Moonga B.S., Lidbury P.S., Hecker M., Vane J.R. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. PNAS 1991, 88:2936-2940.
70. Yaroslavskiy B.B., Zhang Y.J., Kalla S.E., Palacios V.G., Sharrow A.C., Li Y.N., Zaidi M., Wu C.Y., Blair H.C. NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. J. Cell Sci. 2005, 118:5479-5487.
71. Yaroslavskiy B.B., Li Y.N., Ferguson D.J.P., Kalla S.E., Oakley J.I., Blair H.C. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J. Cell. Biochem. 2004, 91:962-972.
72. Mancini L., Moradi-Bidhendi N., Brandi M.L., MacIntyre I. Nitric oxide superoxide and peroxynitrite modulate osteoclast activity. Biochem. Biophys. Res. Commun. 1998, 243:785-790.
73. Jamal S.A., Browner W.S., Bauer D.C., Cummings S.R. Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures. J. Bone Miner. Res. 1998, 13:1755-1759.
74. Wimalawansa S.J., De Marco G., Gangula P., Yallampalli C. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 1996, 18:301-304.
75. Wimalawansa S., Chapa T., Fang L., Yallampalli C., Simmons D., Wimalawansa S. Frequency-Dependent Effect of Nitric Oxide Donor Nitroglycerin on Bone. J. Bone Miner. Res. 2000, 15:1119-1125.
76. Hukkanen M., Platts L.A.M., Lawes T., Girgis S.I., Konttinen Y.T., Goodship A.E., MacIntyre I., Polak J.M. Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Bone 2003, 32:142-149.
77. Wimalawansa S.J. Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J. Bone Miner. Res. 2000, 15:2240-2244.
78. Kdolsky R., Mohr W., Savidis-Dacho H., Beer R., Puig S., Reihsner R., Tangl S., Donath K. The influence of oral l-arginine on fracture healing: an animal study. Wien. Klin. Wochenschr. 2005, 117:693-701.
79. Agvald P., Adding L.C., Gustafsson L.E., Persson M.G. Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo. Eur. J. Pharmacol. 1999, 385:137-145.
80. Khosla S. Is Nitroglycerin a Novel and Inexpensive Treatment for Osteoporosis?. J. Am. Med. Assoc. 2011, 305:826-827.
81. Wimalawansa S.J., Grimes J.P., Wilson A.C., Hoover D.R. Transdermal Nitroglycerin Therapy May Not Prevent Early Postmenopausal Bone Loss. J. Clin. Endocrinol. Metab. 2009, 94:3356-3364.
82. Jamal S.A., Hamilton C.J., Eastell R., Cummings S.R. Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women. J. Am. Med. Assoc. 2011, 305:800-807.
83. Lazzarato L., Rolando B., Lolli M.L., Tron G.C., Fruttero R., Gasco A., Deleide G., Guenther H.L. Synthesis of NO-Donor Bisphosphonates and Their in-Vitro Action on Bone Resorption. J. Med. Chem. 2005, 48:1322-1329.
84. Zhang S.F., Gangal G., Uludag H. 'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. Chem. Soc. Rev. 2007, 36:507-531.
85. Fleisch H.A. Bisphosphonates: preclinical aspects and use in osteoporosis. Ann. Med. 1997, 29:55-62.
86. Papapoulos S.E., Landman J.O., Bijvoet O.L.M., Lowik C., Valkema R., Pauwels E.K.J., Vermeij P. The use of bisphosphonates in the treatment of osteoporosis. Bone 1992, 13:S41-S49.
87. Bone H.G., Hosking D., Devogelaer J., Tucci J.R., Emkey R.D., Tonino R.P., Rodriguez-Portales J.A., Downs R.W., Gupta J., Santora A.C., Liberman U.A., Alendronate Phase I.I.O. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N. Engl. J. Med. 2004, 350:1189-1199.
88. Liberman U.A., Weiss S.R., Broll J., Minne H.W., Quan H., Bell N.H., Rodriguezportales J., Downs R.W., Dequeker J., Favus M., Seeman E., Recker R.R., Capizzi T., Santora A.C., Lombardi A., Shah R.V., Hirsch L.J., Karpf D.B. Effect of oral alendronate on bone-mineral density and the incidence of fractures in postmenopausal osteoporosis. N. Engl. J. Med. 1995, 333:1437-1443.
89. Oura S., Hirai I., Yoshimasu T., Kokawa Y., Sasaki R., Okamura Y. Clinical efficacy of bisphosphonate therapy for bone metastasis from breast cancer. Breast Cancer 2003, 10:28-32.
90. Lolli M.L., Rolando B., Tosco P., Chaurasia S., Stilo A.D., Lazzarato L., Gorassini E., Ferracini R., Oliaro-Bosso S., Fruttero R., Gasco A. Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs). Bioorg. Med. Chem. 2010, 18:2428-2438.
91. Baldik Y., Talu U., Altinel L., Bilge H., Demiryont M., Aykac-Toker G. Bone healing regulated by nitric oxide: an experimental study in rats. Clin. Orthop. Rel. Res. 2002, 404:343-352.
92. Holt J., Hertzberg B., Weinhold P., Storm W., Schoenfisch M., Dahners L. Decreasing Bacterial Colonization of External Fixation Pins Through Nitric Oxide Release Coatings. J. Orthop. Trauma 2011, 25:432-437. 410.1097/BOT.1090b1013e3181f1099ac1098a.
93. Madihally S.V., Matthew H.W.T. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999, 20:1133-1142.
94. Sudarshan N.R., Hoover D.G., Knorr D. Antibacterial action of chitosan. Food Biotechnol. 1992, 6:257-272.
95. Ravi Kumar M. A review of chitin and chitosan applications. React. Funct. Polym. 2000, 46:1-27.
96. Coester L.M., Nepola J.V., Allen J., Marsh J.L. The Effects of Silver Coated External Fixation Pins. Iowa Orthop. J. 2006, 26:48-53.
97. Charville G.W., Hetrick E.M., Geer C.B., Schoenfisch M.H. Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release. Biomaterials 2008, 29:4039-4044.
98. Dobmeier K.P., Schoenfisch M.H. Antibacterial properties of nitric oxide-releasing sol-gel microarrays. Biomacromolecules 2004, 5:2493-2495.
99. Nablo B.J., Chen T.Y., Schoenfisch M.H. Sol-gel derived nitric-oxide releasing materials that reduce bacterial adhesion. J. Am. Chem. Soc. 2001, 123:9712-9713.
100. Nablo B.J., Schoenfisch M.H. Antibacterial properties of nitric oxide-releasing sol-gels. J. Biomed. Mater. Res. A 2003, 67A:1276-1283.
101. Privett B.J., Nutz S.T., Schoenfisch M.H. Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation. Biofouling 2010, 26:973-983.
102. Thomas M.V., Puleo D.A. Infection, Inflammation, and Bone Regeneration. J. Dent. Res. 2011, 90:1052-1061.
103. Alvarez O.M., Goslen J.B., Eaglstein W.H., Welgus H.G., Stricklin G.P. Biology of the dermis: wound healing. Dermatology in general medicine 1987, 1-1598. McGraw Hill Book Co., New York. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedber, K.F. Austen (Eds.).
104. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
105. Singer A.J., Clark R.A.F. Mechanisms of disease-cutaneous wound healing. N. Engl. J. Med. 1999, 341:738-746.
106. Uitto J., Eisen A.Z. Biology of the dermis: collagen. Dermatology in general medicine 1987, 1-1598. McGraw Hill Book Co., New York. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedber, K.F. Austen (Eds.).
107. Bauer E.A., Uitto J. Collagen in cutaneous diseases. Int. J. Dermatol. 1979, 18:251-270.
108. Tymvios C., Moore C., Jones S., Solomon A., Sanz-Rosa D., Emerson M. Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br. J. Pharmacol. 2009, 158:1735-1742.
109. Moore C., Tymvios C., Emerson M. Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase. Thromb. Haemost. 2010, 104:342-349.
110. de Graaf J., Banga J., Moncada S., Palmer R., de Groot P., Sixma J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992, 85:2284-2290.
111. Rizk M., Witte M.B., Barbul A. Nitric oxide and wound healing. World J. Surg. 2004, 28:301-306.
112. Witte M.B., Barbul A. Role of nitric oxide in wound repair. Am. J. Surg. 2002, 183:406-412.
113. Cooke J.P. NO and angiogenesis. Atheroscler. Suppl. 2003, 4:53-60.
114. Schaffer M.R., Efron P.A., Thornton F.J., Klingel K., Gross S.S., Barbul A. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J. Immunol. 1997, 158:2375-2381.
115. Shi H.P., Efron D.T., Most D., Barbul A. The role of iNOS in wound healing. Surgery 2001, 130:225-229.
116. Obayashi K., Akamatsu H., Okano Y., Matsunaga K., Masaki H. Exogenous nitric oxide enhances the synthesis of type I collagen and heat shock protein 47 by normal human dermal fibroblasts. J. Dermatol. Sci. 2006, 41:121-126.
117. Witte M.B., Thornton F.J., Efron D.T., Barbul A. Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide Biol. Chem. 2000, 4:572-582.
118. Schaffer M.R., Tantry U., Thornton F.J., Barbul A. Inhibition of nitric oxide synthesis in wounds: pharmacology and effect on accumulation of collagen in wounds in mice. Eur. J. Surg. 1999, 165:262-267.
119. Shi H.P., Efron D.T., Most D., Tantry U.S., Barbul A. Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice. Surgery 2000, 128:374-378.
120. Lee P.C., Salyapongse A.N., Bragdon G.A., Shears L.L., Watkins S.C., Edington H.D.J., Billiar T.R. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am. J. Physiol. Heart Circ. 1999, 277:1600-1608.
121. Schaffer M.R., Tantry U., Gross S.S., Wasserkrug H.L., Barbul A. Nitric oxide regulates wound healing. J. Surg. Res. 1996, 63:237-240.
122. Stallmeyer B., Anhold M., Wetzler C., Kahlina K., Pfeilschifter J., Frank S. Regulation of eNOS in normal and diabetes-impaired skin repair: implications for tissue regeneration. Nitric Oxide Biol. Chem. 2002, 6:168-177.
123. Yamasaki K., Edington H.D.J., McClosky C., Tzeng E., Lizonova A., Kovesdi I., Steed D.L., Billiar T.R. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 1998, 101:967-971.
124. Muscara M.N., McKnight W., Asfaha S., Wallace J.L. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br. J. Pharmacol. 2000, 129:681-686.
125. Thornton F.J., Schaffer M.R., Witte M.B., Moldawer L.L., MacKay S.L.D., Abouhamze A., Tannahill C.L., Barbul A. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem. Biophys. Res. Commun. 1998, 246:654-659.
126. Shekhter A.B., Serezhenkov V.A., Rudenko T.G., Pekshev A.V., Vanin A.F. Beneficial effect of gaseous nitric oxide on the healing of skin wounds. Nitric Oxide Biol. Chem. 2005, 12:210-219.
127. Hetrick E.M., Shin J.H., Paul H.S., Schoenfisch M.H. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009, 30:2782-2789.
128. Shabani M., Pulfer S.K., Bulgrin J.P., Smith D.J. Enhancement of wound repair with a topically applied nitric oxide-releasing polymer. Wound Repair Regen. 1996, 4:353-362.
129. Amadeu T.P., Seabra A.B., Oliveira M.G., Costa A.M.A. S-nitrosoglutathione-containing hydrogel accelerates rat cutaneous wound repair. J. Eur. Acad. Dermatol. Venereol. 2007, 21:629-637.
130. Amadeu T.P., Seabra A.B., de Oliveira M.G., Monte-Alto-Costa A. Nitric oxide donor improves healing if applied on inflammatory and proliferative phase. J. Surg. Res. 2008, 149:84-93.
131. Evers L.H., Bhavsar D., Mailander P. The biology of burn injury. Exp. Dermatol. 2010, 19:777-783.
132. Becker W.K., Shippee R.L., McManus A.T., Mason A.D., Pruitt B.A. Kinetics of nitrogen-oxide production following experimental thermal-injury in rats. J. Trauma Inj. Infect. Crit. Care 1993, 34:855-862.
133. Carter E.A., Derojaswalker T., Tamir S., Tannenbaum S.R., Yu Y.M., Tompkins R.G. Nitric-oxide production is intensely and persistently increased in tissue by thermal-injury. Biochem. J. 1994, 304:201-204.
134. Paulsen S.M., Wurster S.H., Nanney L.B. Expression of inducible nitric oxide synthase in human burn wounds. Wound Repair Regen. 1998, 6:142-148.
135. Akcay M.N., Ozcan O., Gundogdu C., Akcay G., Balik A., Kose K., Oren D. Effect of nitric oxide synthase inhibitor on experimentally induced burn wounds. J. Trauma Inj. Infect. Crit. Care 2000, 49:327-330.
136. Inoue H., Ando K., Wakisaka N., Matsuzaki K., Aihara M., Kumagai N. Effects of nitric oxide synthase inhibitors on vascular hyperpermeability with thermal injury in mice. Nitric Oxide Biol. Chem. 2001, 5:334-342.
137. Gibran N.S., Boyce S., Greenhalgh D.G. Cutaneous wound healing. J. Burn Care Res. 2007, 28:577-579.
138. Zhu H.F., Ka B., Murad F. Nitric oxide accelerates the recovery from burn wounds. World J. Surg. 2007, 31:624-631.
139. Zhu H.F., Wei X.F., Bian K., Murad F. Effects of nitric oxide on skin burn wound healing. J. Burn Care Res. 2008, 29:804-814.
140. Schaffer M.R., Tantry U., Efron P.A., Ahrendt G.M., Thornton F.J., Barbul A. Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. Surgery 1997, 121:513-519.
141. Le N.N., Rose M.B., Levinson H., Klitzman B. Implant healing in experimental animal models of diabetes. J. Diabetes Sci. Technol. 2011, 5:605-618.
142. Schaffer M., Bongartz M., Fischer S., Proksch B., Viebahn R. Nitric oxide restores impaired healing in normoglycaemic diabetic rats. J. Wound Care 2007, 16:311-316.
143. Witte M.B., Kiyama T., Barbul A. Nitric oxide enhances experimental wound healing in diabetes. Br. J. Surg. 2002, 89:1594-1601.
144. Singh R.J., Hogg N., Joseph J., Konorev E., Kalyanaraman B. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch. Biochem. Biophys. 1999, 361:331-339.
145. Weller R., Finnen M.J. The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice. Nitric Oxide Biol. Chem. 2006, 15:395-399.
146. Mowbray M., Tan X.J., Wheatley P.S., Morris R.E., Weller R.B. Topically applied nitric oxide induces T-Lymphocyte infiltration in human skin, but minimal inflammation. J. Invest. Dermatol. 2008, 128:352-360.
147. Dashti N., Einollahi N., Zarebavani M., Kiani F. The effect of DETA NONOate, a nitric oxide donor, on the rate of collagen synthesis in rat as an animal model of diabetes. Int. J. Vet. Res. 2010, 4:159-161.
148. Li Y., Lee P.I. Controlled Nitric Oxide Delivery Platform Based on S-Nitrosothiol Conjugated Interpolymer Complexes for Diabetic Wound Healing. Mol. Pharmaceutics 2010, 7:254-266.
149. Strachan C.J.L. The prevention of orthopedic implant vascular graft infections. J. Hosp. Infect. 1995, 30:54-63.
150. O'Brien M. Functional anatomy and physiology of tendons. Clin. Sport. Med. 1992, 11:505-520.
151. Andres B.M., Murrell G.A.C. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin. Orthop. Rel. Res. 2008, 466:1539-1554.
152. Murrell G.A.C., Szabo C., Hannafin J.A., Jang D., Dolan M.M., Deng X.H., Murrell D.F., Warren R.F. Modulation of tendon healing by nitric oxide. Inflamm. Res. 1997, 46:19-27.
153. Tomiosso T.C., Nakagaki W.R., Gomes L., Hyslop S., Pimentel E.R. Organization of collagen bundles during tendon healing in rats treated with L-NAME. Cell Tissue Res. 2009, 337:235-242.
154. Molloy T.J., de Bock C.E., Wang Y., Murrell G.A.C. Gene expression changes in SNAP-stimulated and iNOS-transfected tenocytes-expression of extracellular matrix genes and its implications for tendon-healing. J. Orthop. Res. 2006, 24:1869-1882.
155. Xia W., Szomor Z., Wang Y., Murrell G.A.C. Nitric oxide enhances collagen synthesis in cultured human tendon cells. J. Orthop. Res. 2006, 24:159-172.
156. Xia W., Wang Y., Appleyard R., Smythe G.A., Murrell G.A.C. Spontaneous recovery of injured Achilles tendon in inducible nitric oxide synthase gene knockout mice. Inflamm. Res. 2006, 55:40-45.
157. Lin J., Wang M.X., Wei A., Zhu W., Murrell G.A.C. The cell specific temporal expression of nitric oxide synthase isoforms during Achilles tendon healing. Inflamm. Res. 2001, 50:515-522.
158. Lin J.H., Wang M.X., Wei A.Q., Zhu W., Diwan A.D., Murrell G.A.C. Temporal expression of nitric oxide synthase isoforms in healing Achilles tendon. J. Orthop. Res. 2001, 19:136-142.
159. Yuan J., Murrell G.A.C., Wei A.Q., Appleyard R.C., Del Soldato P., Wang M.X. Addition of nitric oxide via nitroflurbiprofen enhances the material properties of early healing of young rat Achilles tendons. Inflamm. Res. 2003, 52:230-237.
160. Murrell G.A.C., Tang G.Y., Appleyard R.C., del Soldato P., Wang M.X. Addition of nitric oxide through nitric oxide-paracetamol enhances healing rat achilles tendon. Clin. Orthop. Rel. Res. 2008, 466:1618-1624.
161. Berrazueta J.R., Losada A., Poveda J., Ochoteco A., Riestra A., Salas E., Amado J.A. Successful treatment of shoulder pain syndrome due to supraspinatus tendinitis with transdermal nitroglycerin. A double blind study. Pain 1996, 66:63-67.
162. Paoloni J.A., Appleyard R.C., Nelson J., Murrell G.A.C. Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow-a randomized, double-blinded, placebo-controlled clinical trial. Am. J. Sports Med. 2003, 31:915-920.
163. Paoloni J.A., Appleyard R.C., Nelson J., Murrell G.A.C. Topical glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathy-a randomized, double-blind, placebo-controlled trial. J. Bone Joint Surg. Am. 2004, 86A:916-922.
164. Paoloni J.A., Appleyard R.C., Nelson J., Murrell G.A.C. Topical glyceryl trinitrate application in the treatment of chronic supraspinatus tendinopathy-a randomized, double-blinded, placebo-controlled clinical trial. Am. J. Sports Med. 2005, 33:806-813.
165. Paoloni J.A., Murrell G.A.C. Three-year followup study of topical glyceryl trinitrate treatment of chronic noninsertional Achilles tendinopathy. Foot Ankle Int. 2007, 28:1064-1068.
166. Kane T.P.C., Ismail M., Calder J.D.F. Topical glyceryl trinitrate and noninsertional Achilles tendinopathy-a clinical and cellular investigation. Am. J. Sports Med. 2008, 36:1160-1163.
167. McCallum S.D.A., Paoloni J.A., Murrell G.A.C. Five-year prospective comparison study of topical glyceryl trinitrate treatment of chronic lateral epicondylosis at the elbow. Br. J. Sports Med. 2011, 45:416-420.
168. Paoloni J.A., Murrell G.A.C., Burch R.M., Ang R.Y. Randomised, double-blind, placebo-controlled clinical trial of a new topical glyceryl trinitrate patch for chronic lateral epicondylosis. Br. J. Sports Med. 2009, 43:299-302.
169. Ignarro L.J., Lippton H., Edwards J.C., Baricos W.H., Hyman A.L., Kadowitz P.J., Gruetter C.A. Mechanism of vascular smooth-muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide-evidence for the involvement of S-nitrosothols as active intermediates. J. Pharmacol. Exp. Ther. 1981, 218:739-749.
170. Park J.W. Reaction of S-nitrosoglutathione with sulfhydryl-groups in protein. Biochem. Biophys. Res. Commun. 1988, 152:916-920.
171. Ewing J.F., Young D.V., Janero D.R., Garvey D.S., Grinnell T.A. Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners. J. Pharmacol. Exp. Ther. 1997, 283:947-954.